Review
Research progress of polymyxin B-associated skin hyperpigmentation
Zhang Shaonan, Huang xiaohui, Yue Huijie
Published 2020-01-28
Cite as ADRJ, 2020, 22(1): 38-41. DOI: 10.3760/cma.j.issn.1008-5734.2020.01.008
Abstract
Polymyxin B is mainly used in the treatment of severe drug-resistant gram-negative bacterial infection. In recent years, more and more cases of skin pigmentation caused by polymyxin B have been reported. The incidence of polymyxin B-related skin pigmentation in infants was higher than that in adults. The mechanism of polymyxin B-induced hyperpigmentation is not clear, which may be related to histamine release, skin inflammation, and the stimulation of melanin synthesis induced by polymyxin B. Although skin pigmentation has no significant effect on the treatment and prognosis in patients, it may cause psychological burden and affect the life quality, which should be paid more attention to and further studied.
Key words:
Polymyxin B; Skin pigmentation; Hyperpigmentation
Contributor Information
Zhang Shaonan
Department of Pharmacology, General Hospital of Eastern Theater Command, Nanjing 21002, China
Department of Pharmacy, the Second People′s Hospital of Wuhu, Anhui Province, Wuhu 241000, China
Huang xiaohui
Department of Pharmacology, General Hospital of Eastern Theater Command, Nanjing 21002, China
Yue Huijie
Department of Pharmacology, General Hospital of Eastern Theater Command, Nanjing 21002, China